98%
921
2 minutes
20
Objective: To develop and evaluate the effectiveness of multimodal machine learning approach for the differentiation of NTM from MTB.
Methods: The clinical data and CT images of 175 patients were retrospectively obtained. We established clinical data-based model, radiomics-based model, and multimodal (clinical plus radiomics) model gradually using 5 machine learning algorithms (Logistic, XGBoost, AdaBoost, RandomForest, and LightGBM). Optimal algorithm in each model was selected after evaluating the differentiation performance both in training and validation sets. The model performance was further verified using external new MTB and NTM patient data. Performance was also compared with the existing approaches and model.
Results: The clinical data-based model contained age, gender, and IL-6, and the RandomForest algorithm achieved the optimal learning model. Two key radiomics features of CT images were identified and then used to establish the radiomics model, finding that model from Logistic algorithm was the optimal. The multimodal model contained age, IL-6, and the 2 radiomics features, and the optimal model was from LightGBM algorithm. The optimal multimodal model had the highest AUC value, accuracy, sensitivity, and negative predictive value compared with the optimal clinical or radiomics models, and its' favorable performance was also verified in the external test dataset (accuracy = 0.745, sensitivity = 0.900). Additionally, the performance of multimodal model was better than that of the radiologist, NGS detection, and existing machine learning model, with an increased accuracy of 26, 4, and 6%, respectively.
Conclusion: This is the first study to establish multimodal model to distinguish NTM from MTB and it performs well in differentiating them, which has the potential to aid clinical decision-making for experienced radiologists.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11872937 | PMC |
http://dx.doi.org/10.3389/fpubh.2025.1470072 | DOI Listing |
Comput Biol Med
September 2025
INSIGNEO Institute for in silico medicine, University of Sheffield, UK; School of Mechanical, Aerospace and Civil Engineering, University of Sheffield, UK. Electronic address:
Modelling cardiovascular disease is at the forefront of efforts to use computational tools to assist in the analysis and forecasting of an individual's state of health. To build trust in such tools, it is crucial to understand how different approaches perform when applied to a nominally identical scenario, both singularly and across a population. To examine such differences, we have studied the flow in aneurysms located on the internal carotid artery and middle cerebral artery using the commercial solver Ansys CFX and the open-source code HemeLB.
View Article and Find Full Text PDFStem Cell Res
September 2025
Department of General Pediatrics, Neonatology, and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf 40225, Germany. Electronic address:
Pathogenic variants in the gene COQ4 cause primary coenzyme Q deficiency, which is associated with symptoms ranging from early epileptic encephalopathy up to adult-onset ataxia-spasticity spectrum disease. We genetically modified commercially available wild-type iPS cells by using a CRISPR/Cas9 approach to create heterozygous and homozygous isogenic cell lines carrying the disease-causing COQ4 variants c.458C > T, p.
View Article and Find Full Text PDFEur J Radiol
September 2025
Department of Radiology, Affiliated Hospital of Hebei University, Baoding 071000, China. Electronic address:
Purpose: The present study aimed to develop a noninvasive predictive framework that integrates clinical data, conventional radiomics, habitat imaging, and deep learning for the preoperative stratification of MGMT gene promoter methylation in glioma.
Materials And Methods: This retrospective study included 410 patients from the University of California, San Francisco, USA, and 102 patients from our hospital. Seven models were constructed using preoperative contrast-enhanced T1-weighted MRI with gadobenate dimeglumine as the contrast agent.
Arch Med Res
September 2025
Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan. Electronic address:
Background: Atherosclerosis, a leading cause of cardiovascular disease (CVD) mortality worldwide, is characterized by dysregulated lipid metabolism and unresolved inflammation. Macrophage-derived foam cell formation and apoptosis contribute to plaque formation and vulnerability. Elevated serum galectin-3 (Gal-3) levels are associated with increased CVD risk, and Gal-3 in plaques is strongly associated with macrophages.
View Article and Find Full Text PDF